Posted by Michael Wonder on 21 Apr 2018
Recommendations made by the PBAC - March 2018
20 April 2018 - The recommendations from the March 2018 PBAC meeting are now available.
71 submissions were considered by the PBAC; 66 relate to the listing of a medicine, medicinal preparation or gene therapy on the Pharmaceutical Benefits Scheme; the remaining five relate to the listing of a vaccine on the National Immunisation Program.
The 71 submissions yielded 115 outcomes; 64 (56%) recommendations, 28 (24%) rejections, 22 (19%) deferrals and 1 (1%) no outcome. Insofar as some submissions included multiple requests; the number of outcomes exceeds the number of submissions.
Detailed analysis in tomorrow's edition.
